Apolipoproteins C-III and A-V as predictors of very-low-density lipoprotein triglyceride and apolipoprotein B-100 kinetics.

Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man

Matthews, D. R., Hosker, J. P., Rudenski, A. S., Naylor, B. A., Treacher, D. F., & Turner, R. C. (1985) · Diabetologia · doi:10.1007/bf00280883 · Cited by 31,502 · see citing works

Summary of the second report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II)

Grundy, S. M., Bilheimer, D. W., Chait, A., Clark, L. T., Denke, M. A., Havel, R. J., Hazzard, W. R., Hulley, S. B., Hunninghake, D. B., Kreisberg, R. A., et al. (1993) · JAMA · doi:10.1001/jama.269.23.3015 · Cited by 27,944 · see citing works

Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)

Expert Panel on Detection, E. (2001) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.285.19.2486 · Cited by 26,011 · see citing works

Hypertriglyceridemic Waist: A Marker of the Atherogenic Metabolic Triad (Hyperinsulinemia; Hyperapolipoprotein B; Small, Dense LDL) in Men?

Lemieux, I., Pascot, A., Couillard, C., Lamarche, B., Tchernof, A., Alméras, N., Bergeron, J., Gaudet, D., Tremblay, G., Prud’homme, D., et al. (2000) · Circulation · doi:10.1161/01.cir.102.2.179 · Cited by 937 · see citing works

Hypertriglyceridemia as a Result of Human apo <i>CII</i> Gene Expression in Transgenic Mice

Ito, Y., Azrolan, N., O'Connell, A., Walsh, A., & Breslow, J. L. (1990) · Science · doi:10.1126/science.2167514 · Cited by 539 · see citing works

VLDL, apolipoproteins B, CIII, and E, and risk of recurrent coronary events in the Cholesterol and Recurrent Events (CARE) trial

Sacks, F. M., Alaupovic, P., Moye, L. A., Cole, T. G., Sussex, B., Stampfer, M. J., Pfeffer, M. A., & Braunwald, E. (2000) · Circulation · doi:10.1161/01.cir.102.16.1886 · Cited by 490 · see citing works

ApoAV Reduces Plasma Triglycerides by Inhibiting Very Low Density Lipoprotein-Triglyceride (VLDL-TG) Production and Stimulating Lipoprotein Lipase-mediated VLDL-TG Hydrolysis

Schaap, F. G., Rensen, P. C. N., Voshol, P. J., Vrins, C. L. J., van der Vliet, H. N., Chamuleau, R. A. F. M., Havekes, L. M., Groen, A. K., & van Dijk, K. W. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m403240200 · Cited by 300 · see citing works

Apolipoprotein AV Accelerates Plasma Hydrolysis of Triglyceriderich Lipoproteins by Interaction with Proteoglycan-bound Lipoprotein Lipase

Merkel, M., Loeffler, B., Kluger, M. A., Fabig, N., Geppert, G., Pennacchio, L. A., Laatsch, A., & Heeren, J. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m411412200 · Cited by 292 · see citing works

Apolipoproteins C-I and C-III as important modulators of lipoprotein metabolism

Shachter, N. S. (2001) · Current Opinion in Lipidology · doi:10.1097/00041433-200106000-00009 · Cited by 288 · see citing works

Overproduction of VLDL 1 Driven by Hyperglycemia Is a Dominant Feature of Diabetic Dyslipidemia

Adiels, M., Borén, J., CASLAKE, M. J., Stewart, P., Soro, A., Westerbacka, J., Wennberg, B., Olofsson, S., Packard, C. J., & Taskinen, M. (2005) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000172689.53992.25 · Cited by 269 · see citing works

The Novel Apolipoprotein A5 Is Present in Human Serum, Is Associated with VLDL, HDL, and Chylomicrons, and Circulates at Very Low Concentrations Compared with Other Apolipoproteins

O'Brien, P. J., Alborn, W. E., Sloan, J. H., Ulmer, M., Boodhoo, A., Knierman, M. D., Schultze, A. E., & Konrad, R. J. (2004) · Clinical Chemistry · doi:10.1373/clinchem.2004.040824 · Cited by 215 · see citing works

Apolipoprotein A5, a Crucial Determinant of Plasma Triglyceride Levels, Is Highly Responsive to Peroxisome Proliferator-activated Receptor α Activators

Vu‐Dac, N., Gervois, P. P., Jäkel, H., Nowak, M., Baugé, E., Dehondt, H., Staels, B., Pennacchio, L. A., Rubin, E. M., Fruchart‐Najib, J., et al. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m212191200 · Cited by 206 · see citing works

Rate of production of plasma and very-low-density lipoprotein (VLDL) apolipoprotein C-III is strongly related to the concentration and level of production of VLDL triglyceride in male subjects with different body weights and levels of insulin sensitivity.

Cohn, J. S., Patterson, B. W., Uffelman, K. D., Davignon, J., & Steiner, G. (2004) · The Journal of Clinical Endocrinology &amp; Metabolism · doi:10.1210/jc.2003-032056 · Cited by 170 · see citing works

Apolipoprotein A5 , a Newly Identified Gene That Affects Plasma Triglyceride Levels in Humans and Mice

Pennacchio, L. A., & Rubin, E. M. (2003) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000054194.78240.45 · Cited by 168 · see citing works

The role and mode of action of apolipoproteins CIII and AV: synergistic actors in triglyceride metabolism?

Willems van Dijk, K., Rensen, P. C., Voshol, P. J., & Havekes, L. M. (2004) · Current Opinion in Lipidology · doi:10.1097/00041433-200406000-00002 · Cited by 154 · see citing works

The APOA1/C3/A4/A5 gene cluster, lipid metabolism and cardiovascular disease risk

Lai, C., Parnell, L. D., & Ordovás, J. M. (2005) · Current Opinion in Lipidology · doi:10.1097/01.mol.0000162320.54795.68 · Cited by 137 · see citing works

Apolipoprotein C-III deficiency accelerates triglyceride hydrolysis by lipoprotein lipase in wild-type and apoE knockout mice

Jong, M. C., Rensen, P. C. N., Dahlmans, V. E. H., van der Boom, H., van Berkel, T. J. C., & Havekes, L. M. (2001) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)32211-2 · Cited by 136 · see citing works

Transcriptional Regulation of Apolipoprotein C-III Gene Expression by the Orphan Nuclear Receptor RORα

Raspé, E., Duez, H., Gervois, P., Fiévet, C., Fruchart, J., Besnard, S., Mariani, J., Tedgui, A., & Staels, B. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m004982200 · Cited by 134 · see citing works

Apolipoprotein B-100 kinetics in visceral obesity: Associations with plasma apolipoprotein C-III concentration

Chan, D. C., Watts, G. F., Redgrave, T. G., Mori, T. A., & Barrett, P. H. R. (2002) · Metabolism · doi:10.1053/meta.2002.33339 · Cited by 133 · see citing works

Apolipoprotein A-V Deficiency Results in Marked Hypertriglyceridemia Attributable to Decreased Lipolysis of Triglyceride-Rich Lipoproteins and Removal of Their Remnants

Grosskopf, I., Baroukh, N., Lee, S., Kamari, Y., Harats, D., Rubin, E. M., Pennacchio, L. A., & Cooper, A. D. (2005) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000186189.26141.12 · Cited by 128 · see citing works

Hepatic secretion of very-low-density lipoprotein apolipoprotein B-100 studied with a stable isotope technique in men with visceral obesity

Riches, F. M., Watts, G. F., Naoumova, R. P., Kelly, J., Croft, K. D., & Thompson, G. (1998) · International Journal of Obesity · doi:10.1038/sj.ijo.0800602 · Cited by 126 · see citing works

Triglyceride-rich lipoproteins and the progression of coronary artery disease

Hodis, H. N., & Mack, W. J. (1995) · Current Opinion in Lipidology · doi:10.1097/00041433-199508000-00004 · Cited by 118 · see citing works

A new combined multicompartmental model for apolipoprotein B-100 and triglyceride metabolism in VLDL subfractions

Adiels, M., Packard, C. J., CASLAKE, M. J., Stewart, P., Soro, A., Westerbacka, J., Wennberg, B., Olofsson, S., Taskinen, M., & Borén, J. (2004) · Journal of Lipid Research · doi:10.1194/jlr.m400108-jlr200 · Cited by 117 · see citing works

Markers of triglyceride-rich lipoprotein remnant metabolism in visceral obesity

Chan, D. C., Watts, G. F., Barrett, P. H., Mamo, J. C., & Redgrave, T. G. (2002) · Clinical Chemistry · doi:10.1093/clinchem/48.2.278 · Cited by 117 · see citing works

A sandwich enzyme-linked immunosorbent assay for human plasma apolipoprotein A-V concentration

Ishihara, M., Kujiraoka, T., Iwasaki, T., Nagano, M., Takano, M., Ishii, J., Tsuji, M., Ide, H., Miller, I. P., Miller, N. E., et al. (2005) · Journal of Lipid Research · doi:10.1194/jlr.d500018-jlr200 · Cited by 97 · see citing works

Metabolism of C-apolipoproteins: kinetics of C-II, C-III1 and C-III2, and VLDL-apolipoprotein B in normal and hyperlipoproteinemic subjects.

Huff, M. W., Fidge, N., Nestel, P. J., Billington, T., & Watson, B. (1981) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)37316-8 · Cited by 90 · see citing works

Increased apoC-III production is a characteristic feature of patients with hypertriglyceridemia

Cohn, J. S., Tremblay, M., Batal, R., Jacques, H., Rodriguez, C., Steiner, G. A., Mamer, O., & Davignon, J. (2004) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2004.06.011 · Cited by 62 · see citing works

Transcriptional Regulation of Apolipoprotein A5 Gene Expression by the Nuclear Receptor RORα

Genoux, A., Dehondt, H., Helleboid‐Chapman, A., Duhem, C., Hum, D. W., Martin, G., Pennacchio, L. A., Staels, B., Fruchart‐Najib, J., & Fruchart, J. (2005) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000163841.85333.83 · Cited by 54 · see citing works

Lipoprotein transport in the metabolic syndrome: pathophysiological and interventional studies employing stable isotopy and modelling methods

Chan, D. C., Barrett, P. H. R., & Watts, G. F. (2004) · Clinical Science · doi:10.1042/cs20040109 · Cited by 44 · see citing works

Metabolism of apolipoproteins CII, CIII1, CIII2 and VLDL-B in human subjects consuming high carbohydrate diets

Huff, M. W., & Nestel, P. J. (1982) · Metabolism · doi:10.1016/0026-0495(82)90240-2 · Cited by 43 · see citing works

Oxazolinone derivative of leucine for GC-MS: a sensitive and robust method for stable isotope kinetic studies of lipoproteins

Dwyer, K. P., Barrett, P. H. R., Chan, D. C., Foo, J. I., Watts, G. F., & Croft, K. D. (2002) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)30177-2 · Cited by 39 · see citing works

Immunologic and Ultrastructural Characterization of HIV Pseudovirions Containing Gag and Env Precursor Proteins Engineered in Insect Cells

Tobin, G. J., Nagashima, K., & Gonda, M. A. (1996) · Methods · doi:10.1006/meth.1996.0096 · Cited by 36 · see citing works

Postprandial increase of plasma apoAV concentrations in Type 2 diabetic patients

Pruneta‐Deloche, V., Ponsin, G., Groisne, L., Fruchart‐Najib, J., Lagarde, M., & Moulin, P. (2005) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2005.01.034 · Cited by 35 · see citing works

ApoA-V

Olofsson, S. (2005) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000167518.27125.b1 · Cited by 22 · see citing works

Model development to describe the heterogeneous kinetics of apolipoprotein B and triglyceride in hypertriglyceridemic subjects

Barrett, P. H. R., Baker, N., & Nestel, P. J. (1991) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)42027-9 · Cited by 22 · see citing works

[12] Immunochemical methods for quantification of human apolipoprotein C-III

Kashyap, M. L. (1996) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/s0076-6879(96)63014-6 · Cited by 3 · see citing works

Evaluation and Treatment of Hypertriglyceridemia: An Endocrine Society Clinical Practice Guideline

Berglund, L., Brunzell, J. D., Goldberg, A. C., Goldberg, I. J., Sacks, F., Murad, M. H., & Stalenhoef, A. F. H. (2012) · The Journal of Clinical Endocrinology &amp; Metabolism · doi:10.1210/jc.2011-3213 · Cited by 887 · see citing works

Overproduction of very low-density lipoproteins is the hallmark of the dyslipidemia in the metabolic syndrome

Adiels, M., Olofsson, S.-O., Taskinen, M.-R., & Borén, J. (2008) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.107.160192 · Cited by 820 · see citing works

The Residual Risk Reduction Initiative: a call to action to reduce residual vascular risk in patients with dyslipidemia

Fruchart, J.-C., Sacks, F., Hermans, M. P., Assmann, G., Brown, W. V., Ceska, R., Chapman, M. J., Dodson, P. M., Fioretto, P., Ginsberg, H. N., et al. (2008) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2008.10.002 · Cited by 463 · see citing works

Apolipoprotein C-III and the Metabolic Basis for Hypertriglyceridemia and the Dense Low-Density Lipoprotein Phenotype

Zheng, C., Khoo, C., Furtado, J., & Sacks, F. M. (2010) · Circulation · doi:10.1161/circulationaha.109.875807 · Cited by 223 · see citing works

Apolipoprotein C-III: from pathophysiology to pharmacology

Norata, G. D., Tsimikas, S., Pirillo, A., & Catapano, A. L. (2015) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2015.07.001 · Cited by 182 · see citing works

Diabetic dyslipidaemia

Adiels, M., Olofsson, S., Taskinen, M., & Borén, J. (2006) · Current Opinion in Lipidology · doi:10.1097/01.mol.0000226115.97436.c0 · Cited by 171 · see citing works

Expression of apolipoprotein C-III in McA-RH7777 cells enhances VLDL assembly and secretion under lipid-rich conditions

Sundaram, M., Zhong, S., Khalil, M. B., Links, P. H., Zhao, Y., Iqbal, J., Hussain, M. M., Parks, R. J., Wang, Y., & Yao, Z. (2009) · Journal of Lipid Research · doi:10.1194/m900346-jlr200 · Cited by 170 · see citing works

The crucial roles of apolipoproteins E and C-III in apoB lipoprotein metabolism in normolipidemia and hypertriglyceridemia

Sacks, F. M. (2015) · Current Opinion in Lipidology · doi:10.1097/mol.0000000000000146 · Cited by 168 · see citing works

Metabolism and Modification of Apolipoprotein B-Containing Lipoproteins Involved in Dyslipidemia and Atherosclerosis

Morita, S. (2015) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.b15-00716 · Cited by 156 · see citing works

Hypertriglyceridemia in the genomic era: a new paradigm

Lewis, G. F., Xiao, C., & Hegele, R. A. (2015) · Endocrine Reviews · doi:10.1210/er.2014-1062 · Cited by 152 · see citing works

Apolipoprotein A-V; a potent triglyceride reducer

Nilsson, S. K., Heeren, J., Olivecrona, G., & Merkel, M. (2011) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2011.07.019 · Cited by 115 · see citing works

A human APOC3 missense variant and monoclonal antibody accelerate apoC-III clearance and lower triglyceride-rich lipoprotein levels

Khetarpal, S. A., Zeng, X., Millar, J. S., Vitali, C., Somasundara, A. V. H., Zanoni, P., Landro, J. A., Barucci, N., Zavadoski, W. J., Sun, Z., et al. (2017) · Nature Medicine · doi:10.1038/nm.4390 · Cited by 109 · see citing works

Rapid turnover of apolipoprotein C-III-containing triglyceride-rich lipoproteins contributing to the formation of LDL subfractions.

Chunyu, Z., Christina, K., Katsunori, I., & Sacks, F. M. (2007) · Journal of Lipid Research · doi:10.1194/jlr.p600011-jlr200 · Cited by 95 · see citing works

An ABC of apolipoprotein C-III: a clinically useful new cardiovascular risk factor?

Chan, D. C., Chen, M. M., Ooi, E. M. M., & Watts, G. F. (2008) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.2007.01678.x · Cited by 85 · see citing works

Plasma apolipoprotein A5 and triglycerides in type 2 diabetes

on behalf of the DALI study group, Dallinga‐Thie, G. M., van Tol, A., Hattori, H., der Zee, L. C. V. V., Jansen, H., & Sijbrands, E. J. G. (2006) · Diabetologia · doi:10.1007/s00125-006-0261-0 · Cited by 87 · see citing works

The role of hypertriglyceridemia in atherosclerosis

Le, N., & Walter, M. F. (2007) · Current Atherosclerosis Reports · doi:10.1007/s11883-007-0006-7 · Cited by 79 · see citing works

Kinetic and Related Determinants of Plasma Triglyceride Concentration in Abdominal Obesity: Multicenter Tracer Kinetic Study

Borén, J., Watts, G. F., Adiels, M., Söderlund, S., Chan, D. C., Hakkarainen, A., Lundbom, J., Lundbom, N., Matikainen, N., Kahri, J., et al. (2015) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.115.305614 · Cited by 72 · see citing works

Long-term effects of fenofibrate on VLDL and HDL subspecies in participants with type 2 diabetes mellitus

Hiukka, A., Leinonen, E., Jauhiainen, M., Sundvall, J., Ehnholm, C., Keech, A. C., & Taskinen, M. R. (2007) · Diabetologia · doi:10.1007/s00125-007-0751-8 · Cited by 68 · see citing works

Very Low Density Lipoprotein Metabolism and Plasma Adiponectin as Predictors of High-Density Lipoprotein Apolipoprotein A-I Kinetics in Obese and Nonobese Men

Chan, D. C., Barrett, P. H. R., Ooi, E. M. M., Ji, J., Chan, D. T., & Watts, G. F. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-1457 · Cited by 66 · see citing works

Exploring apolipoprotein C-III: pathophysiological and pharmacological relevance

Packard, C. J., Pirillo, A., Tsimikas, S., Ference, B. A., & Catapano, A. L. (2023) · Cardiovascular Research · doi:10.1093/cvr/cvad177 · Cited by 65 · see citing works

Plasma Apolipoprotein C-III Transport in Centrally Obese Men: Associations with Very Low-Density Lipoprotein Apolipoprotein B and High-Density Lipoprotein Apolipoprotein A-I Metabolism

Chan, D. C., Nguyen, M. N., Watts, G. F., & Barrett, P. H. R. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-2676 · Cited by 62 · see citing works

Nonalcoholic Fatty Liver Disease as the Transducer of Hepatic Oversecretion of Very-Low-Density Lipoprotein–Apolipoprotein B-100 in Obesity

Chan, D. C., Watts, G. F., Gan, S. K., Wong, A. T. Y., Ooi, E. M. M., & Barrett, P. H. R. (2010) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.109.202275 · Cited by 57 · see citing works

Triglyceride-Rich Lipoprotein-Associated Apolipoprotein C-III Production Is Stimulated by Plasma Free Fatty Acids in Humans

Pavlic, M., Valéro, R., Duez, H., Xiao, C., Szeto, L., Patterson, B. W., & Lewis, G. F. (2008) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.108.169383 · Cited by 52 · see citing works

O-Glycoside Biomarker of Apolipoprotein C3: Responsiveness to Obesity, Bariatric Surgery, and Therapy with Metformin, to Chronic or Severe Liver Disease and to Mortality in Severe Sepsis and Graft vs Host Disease

Harvey, S. B., Zhang, Y., Wilson‐Grady, J., Monkkonen, T., Nelsestuen, G. L., Kasthuri, R. S., Verneris, M. R., Lund, T. C., Ely, E. W., Bernard, G. R., et al. (2008) · Journal of Proteome Research · doi:10.1021/pr800751x · Cited by 43 · see citing works

Rare APOA5 mutations—Clinical consequences, metabolic and functional effects

Talmud, P. J. (2007) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2006.12.010 · Cited by 42 · see citing works

Apolipoprotein CIII bound to apoB-containing lipoproteins is associated with small, dense LDL independent of plasma triglyceride levels in healthy men

Shin, M., & Krauss, R. M. (2010) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2010.02.025 · Cited by 40 · see citing works

Clinical significance of apolipoprotein A5

Tai, E. S., & Ordovás, J. M. (2008) · Current Opinion in Lipidology · doi:10.1097/mol.0b013e328304b681 · Cited by 40 · see citing works

The metabolic and pharmacologic bases for treating atherogenic dyslipidaemia

Chan, D. C., Barrett, P. H. R., & Watts, G. F. (2013) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2013.10.001 · Cited by 40 · see citing works

High-density lipoprotein and transport of cholesterol and triglyceride in blood

Brown, W. V. (2007) · Journal of clinical lipidology · doi:10.1016/j.jacl.2007.02.001 · Cited by 39 · see citing works

The ins (cell) and outs (plasma) of apolipoprotein A-V

Forte, T. M., Shu, X., & Ryan, R. O. (2008) · Journal of Lipid Research · doi:10.1194/jlr.r800050-jlr200 · Cited by 38 · see citing works

Plasma Apolipoprotein B-48 Transport in Obese Men: A New Tracer Kinetic Study in the Postprandial State

Wong, A. T. Y., Chan, D. C., Pang, J., Watts, G. F., & Barrett, P. H. R. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-2477 · Cited by 38 · see citing works

Loganin inhibits the inflammatory response in mouse 3T3L1 adipocytes and mouse model

Li, Y., Li, Z., Shi, L., Zhao, C., Shen, B., Tian, Y., & Feng, H. (2016) · International Immunopharmacology · doi:10.1016/j.intimp.2016.04.026 · Cited by 38 · see citing works

Apolipoprotein profiling as a personalized approach to the diagnosis and treatment of dyslipidaemia

Renee Ruhaak, L., van der Laarse, A., & Cobbaert, C. M. (2019) · Annals of Clinical Biochemistry: International Journal of Laboratory Medicine · doi:10.1177/0004563219827620 · Cited by 38 · see citing works

Association of APOA5 rs662799 and rs3135506 polymorphisms with arterial hypertension in Moroccan patients

Ouatou, S., Ajjemami, M., Charoute, H., Sefri, H., Ghalim, N., Rhaissi, H., Benrahma, H., Barakat, A., & Rouba, H. (2014) · Lipids in Health and Disease · doi:10.1186/1476-511x-13-60 · Cited by 34 · see citing works

Association of APOA5 −1131T>C and S19W gene polymorphisms with both mild hypertriglyceridemia and hyperchylomicronemia in type 2 diabetic patients

Charrière, S., Bernard, S., Aqallal, M., Merlin, M., Billon, S., Perrot, L., Coquil, É. L., Sassolas, A., Moulin, P., & Marçais, C. (2008) · Clinica Chimica Acta · doi:10.1016/j.cca.2008.04.013 · Cited by 31 · see citing works

Altered composition of triglyceride-rich lipoproteins and coronary artery disease in a large case–control study

Hopkins, P. N., Nanjee, M. N., Wu, L. L., McGinty, M. G., Brinton, E. A., Hunt, S. C., & Anderson, J. L. (2009) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2009.05.016 · Cited by 29 · see citing works

Intestinal basolateral lipid substrate transport is linked to chylomicron secretion and is regulated by apoC-III

Li, D., Rodia, C. N., Johnson, Z. K., Bae, M., Muter, A., Heussinger, A. E., Tambini, N. S., Longo, A. M., Dong, H., Lee, J., et al. (2019) · Journal of Lipid Research · doi:10.1194/jlr.m092460 · Cited by 29 · see citing works

The Pathogenic Role of Very Low Density Lipoprotein on Atrial Remodeling in the Metabolic Syndrome

Lee, H., & Lin, Y. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21030891 · Cited by 25 · see citing works

Use of Intralipid for kinetic analysis of HDL apoC-III: evidence for a homogeneous kinetic pool of apoC-III in plasma

Nguyen, M. N., Chan, D. C., Dwyer, K. P., Bolitho, P., Watts, G. F., & Barrett, P. H. R. (2006) · Journal of Lipid Research · doi:10.1194/jlr.m600018-jlr200 · Cited by 23 · see citing works

Effect of hormone replacement therapy on plasma lipoprotein levels and coronary atherosclerosis progression in postmenopausal women according to type 2 diabetes mellitus status

Lamon‐Fava, S., Herrington, D. M., Horvath, K. V., Schaefer, E. J., & Asztalos, B. F. (2010) · Metabolism · doi:10.1016/j.metabol.2010.05.012 · Cited by 22 · see citing works

Improved cholesterol phenotype analysis by a model relating lipoprotein life cycle processes to particle size

van Schalkwijk, D. B., de Graaf, A. A., van Ommen, B., van Bochove, K., Rensen, P. C. N., Havekes, L. M., van de Pas, N. C. A., Hoefsloot, H. C. J., van der Greef, J., & Freidig, A. P. (2009) · Journal of Lipid Research · doi:10.1194/jlr.m800354-jlr200 · Cited by 21 · see citing works

Omega-3 fatty acid ethyl ester supplementation decreases very-low-density lipoprotein triacylglycerol secretion in obese men

Wong, A. T. Y., Chan, D. C., Ooi, E. M. M., Ng, T. W., Watts, G. F., & Barrett, P. H. R. (2013) · Clinical Science · doi:10.1042/cs20120587 · Cited by 20 · see citing works

APOC3 Protein Is Not a Predisposing Factor for Fat-induced Nonalcoholic Fatty Liver Disease in Mice

Cheng, X., Yamauchi, J., Lee, S., Zhang, T., Gong, Z., Muzumdar, R. H., Qu, S., & Dong, H. H. (2017) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.765917 · Cited by 20 · see citing works

The Increase of Apolipoprotein A-V During Postprandial Lipemia Parallels the Response of Triglyceride-Rich Lipoproteins in Type 2 Diabetes

Kahri, J., Fruchart‐Najib, J., Matikainen, N., Fruchart, J., Vakkilainen, J., & Taskinen, M. (2007) · Diabetes Care · doi:10.2337/dc07-0100 · Cited by 18 · see citing works

A Computational Model for the Analysis of Lipoprotein Distributions in the Mouse: Translating FPLC Profiles to Lipoprotein Metabolism

Sips, F. L. P., Tiemann, C. A., Oosterveer, M. H., Groen, A. K., Hilbers, P. A. J., & van Riel, N. A. W. (2014) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1003579 · Cited by 16 · see citing works

Atorvastatin plus omega‐3 fatty acid ethyl ester decreases very‐low‐density lipoprotein triglyceride production in insulin resistant obese men

Ng, T., Ooi, E. M. M., Watts, G. F., Chan, D. C., & Barrett, P. H. R. (2013) · Diabetes Obesity and Metabolism · doi:10.1111/dom.12243 · Cited by 15 · see citing works

Apolipoprotein A5 deficiency aggravates high‐fat diet‐induced obesity due to impaired central regulation of food intake

van den Berg, S. A. A., Heemskerk, M. M., Geerling, J. J., van Klinken, J. B., Schaap, F. G., Bijland, S., Berbée, J. F. P., van Harmelen, V., Pronk, A. C. M., Schreurs, M., et al. (2013) · The FASEB Journal · doi:10.1096/fj.12-225367 · Cited by 15 · see citing works

Mutation Screening of the APOA5 Gene in Subjects with Coronary Artery Disease

Soufi, M., Sattler, A., Kurt, B., & Schaefer, J. R. (2012) · Journal of Investigative Medicine · doi:10.2310/jim.0b013e3182686918 · Cited by 15 · see citing works

Presence of Apolipoprotein C‐III Attenuates Apolipoprotein E‐Mediated Cellular Uptake of Cholesterol‐Containing Lipid Particles by HepG2 Cells

Morita, S., Sakurai, A., Nakano, M., Kitagawa, S., & Handa, T. (2010) · Lipids · doi:10.1007/s11745-010-3498-9 · Cited by 15 · see citing works

FISH OILS, PHYTOSTEROLS AND WEIGHT LOSS IN THE REGULATION OF LIPOPROTEIN TRANSPORT IN THE METABOLIC SYNDROME: LESSONS FROM STABLE ISOTOPE TRACER STUDIES

Watts, G. F., Chan, D. C., Ooi, E., Nestel, P., Beilin, L. J., & Barrett, P. H. R. (2006) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/j.1440-1681.2006.04458.x · Cited by 14 · see citing works

Small dense LDL cholesterol and apolipoproteins C-II and C-III in non-diabetic obese subjects with metabolic syndrome

Filippatos, T. D., Tsimihodimos, V., Kostapanos, M. S., Kostara, C. E., Bairaktari, E. T., Kiortsis, D. N., Tselepis, A. D., & Elisaf, M. (2008) · Cited by 14 · see citing works

Effect of Hypertriglyceridemia on Beta Cell Mass and Function in ApoC3 Transgenic Mice

Liu, Y., Cheng, X., Zhang, T., Lee, S., Yamauchi, J., Xiao, X., Gittes, G. K., Qu, S., Jiang, C., & Dong, H. H. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.707885 · Cited by 14 · see citing works

Hypertriglyceridemia Associated With Abdominal Obesity

Carpentier, A. C. (2015) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.115.306412 · Cited by 12 · see citing works

Kinetics of plasma apolipoprotein C-III as a determinant of diet-induced changes in plasma triglyceride levels

Desroches, S., Ruel, I. L., Deshaies, Y., Paradis, M.-E., Archer, W. R., Couture, P., Bergeron, N., & Lamarche, B. (2007) · European Journal of Clinical Nutrition · doi:10.1038/sj.ejcn.1602673 · Cited by 9 · see citing works

Dyslipidemia in Obesity

Chan, D. C., Pang, J., & Watts, G. F. (2016) · Springer eBooks · doi:10.1007/978-3-319-11251-0_30 · Cited by 8 · see citing works

Lipid Metabolism in Metabolic Syndrome

Borén, J., & Adiels, M. (2013) · Springer eBooks · doi:10.1007/978-3-319-01008-3_8 · Cited by 6 · see citing works

FoxO6-mediated ApoC3 upregulation promotes hepatic steatosis and hyperlipidemia in aged rats fed a high-fat diet

Kim, D. H., Lee, S., Noh, S. G., Lee, J., & Chung, H. Y. (2024) · Aging · doi:10.18632/aging.205610 · Cited by 6 · see citing works

Associations of apolipoprotein A5 with triglyceride, adiponectin and insulin resistance in patients with impaired glucose regulation and type 2 diabetes mellitus

Yan, Y., Deng, H., Jian, L., Su, Y., Li, Y., & Mi, G.-P. (2012) · International Journal of Diabetes in Developing Countries · doi:10.1007/s13410-012-0102-2 · Cited by 4 · see citing works

Dyslipidemia in Obesity

Chan, D. C., Pang, J., & Watts, G. F. (2015) · Springer eBooks · doi:10.1007/978-3-319-12125-3_30-1 · Cited by 5 · see citing works

Role of growth hormone in hepatic and intestinal triglyceride-rich lipoprotein metabolism

Maraninchi, M., Calabrese, A., Nogueira, J. P., Castinetti, F., Mancini, J., Mourre, F., Pietri, L., Benamo, E., Albarel, F., Morange, I., et al. (2021) · Journal of clinical lipidology · doi:10.1016/j.jacl.2021.08.003 · Cited by 4 · see citing works

The forkhead box O family in insulin action and lipid metabolism

Lee, S., Zhu, C., Yamauchi, J., Zhu, P., Feng, X., Qu, S., & Dong, H. H. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-819404-1.00013-0 · Cited by 3 · see citing works

FoxO1

Yamauchi, J., Kim, D. H., & Dong, H. H. (2017) · Springer eBooks · doi:10.1007/978-3-319-67199-4_634 · Cited by 3 · see citing works

Ersonified diagnostic and correction dyslipidemia approach by profiling of apolipoproteins

Kachkovsky, M. A., Vvedenskaya, I. P., Vvedensky, V. Y., Supilnikov, A. A., Ponomareva, J. V., & Milyakova, M. N. (2020) · Bulletin of the Medical Institute REAVIZ (REHABILITATION DOCTOR AND HEALTH) · doi:10.20340/vmi-rvz.2020.4.11 · Cited by 1 · see citing works

Apolipoprotein Gene Structure and Function

Martín-Campos, J. M., Chang, B. H.-J., Blanco‐Vaca, F., Chan, L., & Julve, J. (2017) · Encyclopedia of Life Sciences · doi:10.1002/9780470015902.a0005909.pub3 · Cited by 1 · see citing works

Implementation of stable isotopes lipoprotein kinetic studies: effects on HDL metabolism of a Mediterranean type diet rich in MUFAs from virgin olive oil.

Cugat, K. U. (2007) · TDX (Tesis Doctorals en Xarxa)

Novel factors affecting clearance of triacylglycerol-rich lipoproteins from blood

Nilsson, S. K. (2010)

Running title: Postprandial apoA-V in type 2 diabetes

Kahri, J., Fruchart-Najib, J., Matikainen, N., Fruchart, J., Vakkilainen, J., & Taskinen, M. (2007)

Apolipoprotein Gene Structure and Function

Huey, P. U., Chang, B. H.-J., & Chan, L. (2007) · Encyclopedia of Life Sciences · doi:10.1002/9780470015902.a0005909.pub2

FoxO1

Yamauchi, J., Kim, D. H., & Dong, H. H. (2016) · Springer eBooks · doi:10.1007/978-1-4614-6438-9_634-1

Independent regulation of plasma apolipoprotein C–II and C–III concentrations in very low density and high density lipoproteins: implications for the regulation of the catabolism of these lipoproteins

Le, N. A., Gibson, J. C., & Ginsberg, H. N. (1988) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)38512-6 · Cited by 103 · see citing works

Plasma Apolipoprotein C-III Transport in Centrally Obese Men: Associations with Very Low-Density Lipoprotein Apolipoprotein B and High-Density Lipoprotein Apolipoprotein A-I Metabolism

Chan, D. C., Nguyen, M. N., Watts, G. F., & Barrett, P. H. R. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-2676 · Cited by 62 · see citing works

Plasma Apolipoprotein C-III Transport in Centrally Obese Men: Associations with Very Low-Density

Lipoprotein Apolipoprotein, B., Apolipoprotein, L., Metabolism, A.-I., Chan, D. C., Nguyen, M. N., Watts, G. F., Hugh, P., & Barrett, R. (2013)

Triglyceride‐rich lipoprotein metabolism in women: roles of apoC‐ II and apoC‐ III

Ooi, E. M. M., Chan, D. C., Hodson, L., Adiels, M., Borén, J., Karpe, F., Fielding, B. A., Watts, G. F., & Barrett, P. H. R. (2016) · European Journal of Clinical Investigation · doi:10.1111/eci.12657 · Cited by 12 · see citing works

Plasma kinetics of apoC-III and apoE in normolipidemic and hypertriglyceridemic subjects.

Batal, R., Tremblay, M., Barrett, P. H. R., Jacques, H., Fredenrich, A., Mamer, O., Davignon, J., & Cohn, J. S. (2000) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)32379-8 · Cited by 113 · see citing works